Home > EASD Highlights
    • FILTER YOUR SEARCH
    Speciality:
    More Specialities

    • EASD Highlights

    Diabetes
    Juliana Chan, EASD 2020 – COVID-19 and type 1 diabetes
    Watch Time: 8:52 mins

    We spoke with Prof. Juliana Chan (The Chinese University of Hong Kong, Hong Kong) following her session on COVID-19 and the impact on patients with type 1 diabetes. Questions What key areas of diabetes and COVID-19 were discussed at EASD 2020? (0:05) How do you think the COVID-19 pandemic has affected treatment both now and […]

    Diabetes
    Tina Vilsbøll, EASD 2020 – Oral GLP-1RA therapy and individualized care
    Watch Time: 5:13 mins

    We were delighted to speak with Prof. Tina Vilsbøll (University of Copenhagen, Copenhagen, Denmark) about the approval of semaglutide and the impact on the GLP-1RA landscape, and the movement towards individualizing care in patients with type 2 diabetes. Questions What has been the impact of the approval of oral semaglutide in the GLP-1RA landscape? (0:15) […]

    Diabetes
    Gian Paolo Fadini, EASD 2020 – Highlights from EASD 2020
    Watch Time: 4:30 mins

    We were delighted to speak with Dr Gian Paolo Fadini (University of Padova, Venetian Institute of Molecular Medicine, Padova, Italy) about his highlights from the virtual EASD 2020 meeting.   Disclosures: Dr Gian Paolo Fadini has received lecture fees or grant support from Abbott, AstraZeneca, Boehringer, Lilly, Merck-Sharp and Dohme, Mundipharma, Novartis Novo Nordisk, Sanofi […]

    Diabetes
    Gian Paolo Fadini, EASD 2020 – Highlights from the Minkowski Lecture
    Watch Time: 11:04 mins

    We were delighted to catch-up with Dr Gian Paolo Fadini (University of Padova, Venetian Institute of Molecular Medicine, Padova, Italy) to talk about his Minkowski Lecture on bone marrow, circulating stem cells and diabetes.   Disclosures: Dr Gian Paolo Fadini has received lecture fees or grant support from Abbott, AstraZeneca, Boehringer, Lilly, Merck-Sharp and Dohme, […]

    Diabetes
    Mathias Ried-Larsen, EASD 2020 – Effects of cycling and mortality rates in patients with diabetes
    Watch Time: 7:12 mins

    We caught up with Dr Mathias Ried-Larsen (Centre for Physical Activity Research, Rigshospitalet) to discuss the results of his study into the effects of cycling on all-cause and cardiovascular mortality among people with diabetes. Questions Tell us about your study into the effects of cycle training on all-cause and cardiovascular mortality? (0:06) What challenges affect […]

    Diabetes
    Frank Snoek, EASD 2020 – Psychological aspects of diabetes
    Watch Time: 9:40 mins

    Prof. Frank Snoek (Amsterdam University Medical Centers, Amsterdam, The Netherlands) founder and member of the PSAD Study Group, discusses the key psychosocial issues patients face on a daily basis and during the COVID-19 pandemic. Disclosures: Prof. Frank Snoek has nothing to disclose. Support: Interview and filming supported by Touch Medical Media. Filmed as a highlight […]

    Diabetes
    Frank Snoek, EASD 2020 – Celebrating 25 years of the PSAD Study Group
    Watch Time: 8:25 mins

    We were honoured to speak with Prof. Frank Snoek (Amsterdam University Medical Centers, Amsterdam, The Netherlands) founder and member of the PSAD Study Group, who celebrated their 25th anniversay at EASD 2020. Prof. Snoek discusses the rationale behind setting the group up and their mission. Disclosures: Prof. Frank Snoek has nothing to disclose. Support: Interview […]

    Diabetes
    Mikael Rydén, EASD 2020 – Highlights from EASD 2020
    Watch Time: 0:50 mins

    We were delighted to speak with Dr Mikael Rydén (Honorary Secretary EASD 2020 and Karolinska Institutet, Stockholm, Sweden) about his highlights from this year’s virtual meeting.   Disclosures: Dr Mikael Rydén has nothing to disclose in relation to this video. Support: Interview and filming supported by Touch Medical Media. Filmed as a highlight of the […]

    Diabetes
    Teresa Quattrin, EASD 2020 – Updates from the T1GER study

    We spoke with Teresa Quattrin (University at Buffalo, Oishei Children’s Hospital) following her presentation of the T1GER study, which investigated the effect of treatment with golimumab in children, adolescents, and young adults with newly diagnosed type 1 diabetes. Disclosures: Tersea Quattrin discloses the following: Consultant to Janssen Research & Development Clinical Trial, Principal Investigator at […]

    Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72